EAM
JAZZ icon

EverPoint Asset Management’s Jazz Pharmaceuticals JAZZ Stock Holding History

EverPoint Asset Management’s Portfolio JAZZ Stock Details JAZZ Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2016
Q4 		$5.56M Buy
+51,000
New +$5.68M 0.1% 234
2016
Q2 		– Sell
-160,000
Closed -$20.9M – 450
2016
Q1 		$20.9M Buy
+160,000
New +$19.9M 0.41% 53

Other funds holding JAZZ

PI
Putnam Investments Boston, Massachusetts $75.7B AUM 34.45% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
Renaissance Technologies
Renaissance Technologies New York $63.9B AUM 45.56% 1-Year Est. Return
CCM
Cadian Capital Management New York $821M AUM 14.36% 1-Year Est. Return
Bank of New York Mellon
Bank of New York Mellon New York $544B AUM 28.31% 1-Year Est. Return
Westfield Capital Management
Westfield Capital Management Boston, Massachusetts $23.8B AUM 49.45% 1-Year Est. Return
Fidelity International
Fidelity International Hamilton, Bermuda $129B AUM 30.83% 1-Year Est. Return
BFA
BlackRock Fund Advisors San Francisco, California $542B AUM 18.13% 1-Year Est. Return
BIT
BlackRock Institutional Trust San Francisco, California $675B AUM 16.07% 1-Year Est. Return

EverPoint Asset Management's JAZZ Position: Q4 2016 in Review

EverPoint Asset Management opened a new position in Jazz Pharmaceuticals (JAZZ) in Q4 2016: 51,000 shares worth $5.56M. The stake represents 0.1% of the portfolio and ranks #234 among its holdings. This is a return to the name: EverPoint Asset Management previously reported a position in JAZZ as recently as Q1 2016.

EverPoint Asset Management first reported a position in JAZZ in Q1 2016 and has held it in 2 quarters since. The position peaked at $20.9M in Q1 2016. 295 funds tracked by Wall St. Rank hold JAZZ as of Q4 2016.

  • EverPoint Asset Management held 51,000 shares of Jazz Pharmaceuticals worth $5.56M as of Q4 2016.
  • Jazz Pharmaceuticals was a new EverPoint Asset Management position in Q4 2016.
  • Jazz Pharmaceuticals made up 0.1% of EverPoint Asset Management's portfolio in Q4 2016, its #234 holding.
  • EverPoint Asset Management first reported a position in Jazz Pharmaceuticals in Q1 2016 and has held it in 2 quarters since.
  • EverPoint Asset Management's Jazz Pharmaceuticals position peaked at $20.9M in Q1 2016.
  • 295 funds tracked by Wall St. Rank held Jazz Pharmaceuticals as of Q4 2016.

Based on EverPoint Asset Management's 13F filing for Q4 2016, filed 14 Feb 2017.